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Abstract
Introduction: The objective of this study was to determine the ability of various parameters commonly used for
the diagnosis of acute meningitis to differentiate between bacterial and viral meningitis, in adult patients with a
negative direct cerebrospinal fluid (CSF) examination.
Methods: This was a prospective study, started in 1997, including all patients admitted to the emergency unit with
acute meningitis and a negative direct CSF examination. Serum and CSF samples were taken immediately on
admission. The patients were divided into two groups according to the type of meningitis: bacterial (BM; group I)
or viral (VM; group II). The CSF parameters investigated were cytology, protein, glucose, and lactate; the serum
parameters evaluated were C-reactive protein and procalcitonin. CSF/serum glucose and lactate ratios were also
assessed.
Results: Of the 254 patients with meningitis with a negative direct CSF examination, 35 had BM and 181, VM. The
most highly discriminative parameters for the differential diagnosis of BM proved to be CSF lactate, with a
sensitivity of 94%, a specificity of 92%, a negative predictive value of 99%, a positive predictive value of 82% at a
diagnostic cut-off level of 3.8 mmol/L (area under the curve (AUC), 0.96; 95% confidence interval (CI), 0.95 to 1),
and serum procalcitonin, with a sensitivity of 95%, a specificity of 100%, a negative predictive value of 100%, and a
positive predictive value of 97% at a diagnostic cut-off level of 0.28 ng/ml (AUC, 0.99; 95% CI, 0.99 to 1).
Conclusions: Serum procalcitonin and CSF lactate concentrations appear to be the most highly discriminative
parameters for the differential diagnosis of BM and VM.
Introduction
The emergency therapeutic management of meningitis
involves rapid identification of the bacterial or viral nat-
ure of this disease, so that antibiotic treatment can be
started without delay [1], even though the relation
between prognosis and delay in starting antibiotic ther-
apy has not been clearly established [2-5].
The immediate identification of bacterial meningitis
(BM) is based on direct examination of the cerebrosp-
inal fluid (CSF) or the detection of bacterial antigens in
the CSF. These tests have a low sensitivity, and in 30%
to 50% of cases, they do not contribute to differential
diagnosis [6-9].
A model for predicting the bacterial origin of meningi-
tis was proposed by Hoen et al., [10-13], but the results
of external validation tests were not homogeneous.
The preliminary results of our study suggested that
serum procalcitonin and CSF lactate levels were better
markers than were those classically used with regard to
differentiating between BM and viral meningitis (VM) in
patients with meningitis and a negative direct CSF
examination [13]. The objective of this new analysis was
to test the validity of these preliminary results.
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This was a prospective study, including all adult patients
admitted to the emergency unit with suspected meningi-
tis from January 1997 onward. Patients included in this
study provided written informed consent. However, and
in accord with the French law, this study did not
required ethical approval because of the observational
nature of study. This study received the agreement of
the French Data Protection Authority.
Lumbar puncture was performed immediately on the
patient’s admission to the emergency unit. Patients with
meningitis, defined by a leukocyte count > 5 per mm
3
in the CSF, were eligible for inclusion in the study.
Exclusion criteria comprised the presence of bacteria in
the CSF evidenced by direct examination and/or detec-
tion of bacterial antigens in the CSF, antibiotic treat-
ment before admission (more than two successive doses
of the prescribed antibiotic), the presence of another
focus of infection in addition to meningitis, and menin-
gitis finally assumed to be of bacterial origin, despite the
absence of microbiologic documentation, and treated
with antibiotics during the patient’s hospitalization.
Blood tests (complete blood count, C-reactive protein
(CRP), lactate, procalcitonin (PCT), electrolytes, blood
cultures), and CSF analyses (cytology, bacteriology, lac-
tate, protein, glucose) were performed on the admission
of the patient, before the start of any antibiotic treat-
ment. The limits of detection were 0.07 ng/ml for PCT
(Kriptor; Brahms, France), 4 mg/L for CRP (turbidi-
metric method; Diagam, France) and 1.25 mmol/L for
lactate (i-STAT; Abbott, USA). The CSF/serum glucose
and lactate ratios also were calculated. Between 1997
and 1999, neurotropic viruses were identified on the
basis of two serologic examinations separated by an
interval of 15 days and/or detection of the viral genome
by using a polymerase chain reaction (PCR) amplifica-
tion technique. After 1999, only PCR tests were used for
virus identification in the CSF.
BM was diagnosed on the basis of a positive bacterial
culture of CSF. The diagnosis of viral meningitis or
meningoencephalitis was confirmed in the absence of
any bacteria detectable by direct CSF examination or in
bacterial cultures, and a positive viral serology or PCR
test; in the absence of proven viral etiology, meningitis
was considered to be viral if a cure was achieved with-
out any antibiotic treatment apart from antiviral therapy.
In view of their practically identical cytologic and che-
mical characteristics, VM and viral meningoencephalitis
(VME) were combined in a single VM group. The con-
firmed diagnosis was that recorded on the patient’sd i s -
charge from hospital. From 1997 onward, all patients
with meningitis were contacted between 28 and 30 days
after their discharge from hospital to obtain information
on the following items: need for readmission to hospital,
new antibiotic prescription, and persistence or recur-
rence of headache.
Statistical analysis
To determine the value of the different parameters for
the differential diagnosis of BM and VM, the patients
were divided into two groups: those with BM (group I)
and those with VM (group II). The results were
expressed as the mean ± standard deviation. Mean
values were compared by using the Mann-Whitney non-
parametric test, the threshold of statistical significance
being set at P < 0.05. The discriminative power of the
various parameters studied was determined by means of
receiver operating characteristic (ROC) curves. The
diagnostic cut-off level for differentiation of BM and
VM was defined according to the maximum value of the
Youden index. The ROC curves were compared by
using Hanley’s method [14].
Results
Between January 1997 and December 2009, 97 patients
with BM and 218 patients with VM (183 with VM and
35 with VME) were admitted to the emergency unit of
the Saint-Etienne University Hospital.
Among the 97 patients with BM, 62 cases were
excluded: 42 had a positive direct CSF examination, 16
had an additional focus of infection (pulmonary
(eight), in the ear, nose, and throat region (three), asci-
tic (two), intra-abdominal (two), one had a spondylitis
with discitis), and four patients had meningitis
assumed to be of bacterial origin in the absence of
microbiologic documentation. In the CSF samples
taken from these four patients, the polynuclear neutro-
phil count ranged from 964 to 1,480/mm
3;p r o t e i n ,
from 3.8 to 8.3 g/L; glucose, from 1 to 2.8 mmol/L;
and lactate, from 5 to 9.2 mmol/L. These four patients
received antibiotic treatment for 18 to 22 days and
were cured with no sequelae. A CSF fistula was diag-
nosed in one of the four patients.
Thirty-five patients with BM and a negative direct CSF
examination were included in this study. The following
bacteria were identified in CSF cultures: Streptococcus
pneumoniae (14), Listeria monocytogenes (6), Neisseria
meningitidis (5), Streptococcus sp. (4), Haemophilus
influenzae (2), Staphylococcus aureus (2), and other spe-
cies (2). A single bacterial species was identified in the
blood cultures of 14 patients.
Among the 218 patients with VM, the virus was iden-
tified in 85 patients (39%): enterovirus (53), herpes virus
(25), varicella zoster virus (five), and Paramyxovirus (2).
In eight of these patients, admitted prior to 1999, virus
identification was based on serology alone.
The main clinical characteristics of the patients are
presented in Table 1.
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Page 2 of 9The mean values of the serum parameters studied are
shown in Table 2 for each group. With the exception of
serum glucose, these values differed to a statistically sig-
nificant extent between the two groups. CRP levels < 30
mg/L were noted in 10 patients in the BM group. CRP
levels > 30 mg/L were seen in 25% of patients in the
VM group. Only PCT values showed no overlap
between the BM and VM groups. However, two patients
with BM (bacterial species identified: Listeria monocyto-
genes and Haemophilus influenzae, respectively) had low
P C Tv a l u e s :0 . 2 0a n d0 . 2 8n g / m l .T h eC S Fs a m p l e s
taken from these two patients showed a neutrophil
count < 100/mm
3 and normal glucose levels (> 3 mmol/
L), but the other CSF parameters studied allowed confir-
mation of the bacterial origin of meningitis according to
the diagnostic cut-off levels specified in this article. In
all the other patients with BM, PCT levels were > 0.93
ng/ml.
The mean values of the CSF parameters studied and
the CSF/serum glucose and lactate levels are presented
in Table 3. With regard to CSF parameters, 50% of the
patients in the BM group had a neutrophil count < 440/
mm
3, whereas > 10% of the patients in the VM group
had a neutrophil count > 500/mm
3. CSF glucose levels
were not depressed in 25% of the patients with BM, but
lower-than-normal CSF glucose levels were seen in 5%
of patients with VM. CSF protein levels were elevated in
> 25% of patients with VM and were normal in 5% of
patients with BM.
The sensitivity, specificity, and positive and negative
predictive values of the various parameters studied are
presented in Table 4. The ROC curves are illustrated in
Figures 1 and 2. Comparison of the ROC curves showed
no statistically significant difference between PCT and
CSF lactate (P = 0.1). In contrast, statistically significant
differences were seen between PCT and CRP (P =
0.018), between PCT and CSF protein (P =0 . 0 2 ) ,a n d
between PCT and the other parameters.
Finally, among the 183 patients with VM, 31 (17%)
received antibiotic treatment for a period ranging from
8 to 24 hours on the assumption that their meningitis
was of bacterial origin. All patients with BM received
empirical antibiotic treatment in the emergency unit.
Discussion
These results confirm the value of serum PCT and CSF
lactate assays for the differentiation of bacterial and viral
meningitis in adult patients with a negative direct CSF
examination in the emergency unit.
Clinical signs have been shown to have a low sensitiv-
ity and specificity for the diagnosis of meningitis and
are of no value for differentiating between meningitis of
Table 1 Clinical characteristics of patients on admission expressed as means (± standard deviation) or numbers (%)
Characteristics Bacterial meningitis n = 35 Viral meningitis n = 218 P
Demographic characteristics
Mean age (years) 55 ± 20 35 ± 18 ns
Male, n (%) 17 (48) 116 (53) ns
Clinical characteristics
Temperature, n (%) 38.9 ± 0.2 39.1 ± 0.2 ns
Headache, n (%) 14 (40) 158 (72) 0.0001
Nuchal rigidity, n (%) 16 (46) 121 (55) ns
Seizures, n (%) 3 (9) 4 (2) 0.02
Focal neurologic signs, n (%) 2 (6) 6 (3) ns
Confusion 11 (31) 31 (14) 0.01
CGS (mean score ± SD) 13 ± 2 14 ± 2 ns
SAPS II 18 ± 9 8 ± 4 0.0001
CGS, Coma Glasgow Scale; SAPS II, simplified acute physiologic score II.
Table 2 Mean values (± standard deviation) of biochemical serum parameters
Bacterial meningitis n = 35 Viral meningitis n = 218 P
Glucose level (mmol/L)
(min - max)
8.4 ± 2.7
(4.9-14.6)
6.1 ± 1.8
(4-18)
0.03
Lactate (mmol/L)
(min - max)
3 ± 1.8
(1-8)
1.8 ± 1.7
(1-7)
0.0001
Procalcitonin (ng/ml)
(min - max)
17 ± 45
(0.2-257)
0.09 ± 0.03
(0.07-0.1)
0.0001
C-reactive protein (mg/L)
(min - max)
159 ± 148
(19-660)
42 ± 39
(3-152)
0.0001
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Page 3 of 9bacterial and viral origins [15]. In the absence of any
contraindication, a lumbar puncture should always be
performed in patients with suspected meningitis on clin-
ical grounds [16]. However, in the emergency context,
direct CSF examination provides evidence of bacterial
meningitis in only 60% to 80% of cases [8,10]. Diagnosis
is therefore based on the analysis of cytochemical CSF
and serum parameters.
Few published studies have focused on the value of
these parameters for the differential diagnosis of BM in
patients with a negative direct CSF examination, so it is
difficult to compare their results.
Spanos [8] described a study in 55 patients with BM
and a negative direct CSF examination. The median
neutrophil count in the CSF of these patients was 512/
mm
3, compared with 1,520/mm
3 in the CSF of 134
patients with BM and a positive direct CSF examination;
the difference between these groups was statistically sig-
nificant. Ray et al. [17] reported a mean neutrophil
count of 428/mm
3 in 18 patients with BM and a nega-
tive direct CSF examination. In this study, neutrophil
count had a sensitivity of 78% and a specificity of 75%
for the differential diagnosis of BM. In our study, this
parameter was among those most poorly discriminating
between BM and VM, with a sensitivity of 80% and a
specificity of 85% at a diagnostic cut-off level of 118/
mm
3.
Low CSF glucose levels (2 to 2.5 mmol/L) and a low
CSF/serum glucose ratio (on the order of 0.30 to 0.40)
have been classically described as a feature of BM
[18-22]. Spanos [8] reported a median CSF glucose level
of 3.4 mmol/L (CSF/serum glucose ratio, 0.45) in
patients with BM and a negative direct examination of
the CSF, compared with 1.7 mmol/L (CSF/serum glu-
cose ratio, 0.23) in 134 patients with BM and a positive
direct CSF examination. Similar values were seen in the
patients included in our study, although CSF glucose
levels were more markedly reduced.
Elevated CSF protein levels are also seen in patients
with BM, mean values ranging from 1 to 2.5 g/L
[8,17,21,23]. With regard to the differential diagnosis of
BM, the reported sensitivity of this parameter ranged
Table 3 Mean values (± standard deviation) of cytologic and biochemical cerebrospinal fluid parameters
Bacterial meningitis n = 35 Viral meningitis n = 218 P
Leucocyte count/mm
3
(min - max)
1,515 ± 2,000
(25-10,320)
257 ± 520
(23-6,500)
0.0001
Neutrophil count/mm
3
(min - max)
1,003 ± 2,000
(22-10,000)
75 ± 160
(15-1,188)
0.0001
Glucose level (mmol/L)
(min - max)
2.5 ± 1.5
(0.1-5)
3.4 ± 1
(2.1-14)
0.0001
CSF/serum glucose ratio
(min - max)
0.24 ± 0.3
(0.1-0.5)
0.51 ± 0.15
(0.3-1.8)
0.01
Lactate (mmol/L)
(min - max)
9±5
(3.2-25)
2.6 ± 1.6
(0.5-3.7)
0.0001
CSF/serum lactate ratio
(min - max)
3.7 ± 2.7
(1.5-8.4)
1.5 ± 1.4
(1-1.9)
0.0001
Protein level (g/L)
(min - max)
4.9 ± 4.6
0.5-24
1 ± 0.6
0.3-4
0.0001
Table 4 Diagnostic value of the various parameters studied
CSF parameters Serum parameters CSF/serum ratio
Neutrophil/
mm
3
Protein
g/L
Glucose
mmol/L
Lactate
mmol/L
PCT ng/
ml
CRP
mg/l
Glucose CSF/
serum
Lactate CSF/
serum
AUC 0.86 0.93 0.69 0.96 0.99 0.92 0.87 0.84
[CI 95%] [0.86-0.94] [0.92-0,98] [0.69-0.76] [0.95-1] [0.99-1] [0.92-
0.98]
[0.86-0.91] [0.84-0.93]
Optimal cut-point 118 1.88 2.2 3.8 0.28 37 0.48 2.22
Sensitivity 0.80 0.89 0.97 0.94 0.97 0.86 0.84 0.79
Specificity 0.85 0.93 0.49 0.97 1 0.84 0.89 0.89
Positive predictive
value
0.47 0.67 0.92 0.82 0.97 0.46 0.98 0.52
Negative predictive
value
0.96 0.98 0.71 0.99 1 0.97 0.66 0.97
Global value 0.84 0.92 0.90 0.96 0.99 0.84 0.76 0.87
AUC, area under a curve; CI, confidence interval; CSF, cerebrospinal fluid.
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Page 4 of 9from 63% to 86% with a specificity of 94% to 98%
[17,21]. Normal CSF protein values were found in 10%
of patients with BM and a negative direct CSF examina-
tion [8]. In our study, a CSF protein level of 1.88 g/L
gave a sensitivity of 89% and a specificity of 93% for the
diagnosis of BM. Normal levels of protein in the CSF
were seen in 5% of the patients with BM in our study.
Although several studies have demonstrated the value
of determining lactate levels in the CSF for the differen-
tial diagnosis of BM, none of these focused specifically
on the diagnostic value of this parameter in adult
patients with BM and a negative direct CSF examination
[21,23-27]. Furthermore, its use in this context was not
recommended by the last-but-one French consensus
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Figure 1 Receiver operating characteristic (ROC) curves of the two most highly discriminative parameters (CSF, cerebrospinal fluid; Se,
serum).
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Page 5 of 9conference on the management of BM, notably on the
grounds of the disparity of the diagnostic cut-off levels
reported and the methods used to determine these [28].
In addition, the selection of the control groups com-
pared with the BM group could be a confounding factor
with regard to interpretation of the results. In some stu-
dies, the BM group was compared with heterogeneous
groups of patients with pathologic conditions likely to
induce elevated lactate concentrations in the CSF (for
example, brain tumor, subdural hemorrhage, trauma,
and coma of metabolic origin) [19,27]. In studies com-
paring a group of patients with BM with a group of
patients with VM, the cut-off level for the differential
diagnosis of BM (correctly defined by ROC curves) ran-
ged from 3.2 to 4 mmol/L with a sensitivity of 78% to
100% and a specificity of 96% to 100% [29-31]. In our
study, with a diagnostic cut-off value of 3.8 mmol/L, the
sensitivity for the differential diagnosis of BM was 94%,
with a specificity of 97%. This was one of the two para-
meters that discriminated best between BM and VM in
our study, based on comparisons between the different
ROC curves. The most recent French consensus confer-
ence on the management of BM emphasizes the value
of this marker [32].
The value of serum levels of C-reactive protein, a pro-
tein characteristic of the acute phase of inflammation, in
differentiating BM and VM, was investigated in several
published studies, as well as in a meta-analysis (includ-
ing 14 studies in which serum levels of C-reactive pro-
tein were measured) [17,26,33-35]. The cut-off levels for
the differential diagnosis of BM ranged from 20 to 100
mg/L [35]. The best compromise between sensitivity
and specificity seemed to be achieved at diagnostic cut-
off levels between 20 and 50 mg/L, although even in
this case, the sensitivity and specificity were still less
than 80%, notably with regard to adult patients with
acute meningitis and a negative direct CSF examination
[17]. In our study, the contribution of serum C-reactive
protein to the diagnosis of BM was inferior to that of
CSF protein and lactate and serum PCT, with a sensitiv-
ity of 86% and a specificity of 84% at a diagnostic cut-
off level of 37 mg/L.
PCT is another marker that has been evaluated with
regard to its usefulness in distinguishing between
infections of bacterial and viral origin. Serum levels of
this marker increase within 2 hours after stimulation
of inflammatory processes, as shown in healthy volun-
teers receiving an injection of lipopolysaccharides [36].
The first studies on PCT in the context of BM, in
adults and children, were published in 1997 and 2000
[9,31,37,38]. Serum PCT was found to be capable of
differentiating BM (23 cases in children and 32 in
a d u l t s )f r o mV Mi n1 0 0 %o fc a s e s ,b u tt h ed i a g n o s t i c
cut-off levels used ranged from 0.20 ng/ml to 2 ng/ml.
Other studies subsequently completed these data in
adults with conflicting results. In the study reported by
Schwarz et al. [39], among 16 patients with BM, five
showed serum PCT levels < 0.5 ng/ml, the bacterial
species identified in these patients being Mycobacter-
ium tuberculosis (one), Borrelia burgdorferi (one), Sta-
phylococcus aureus (one), Haemophilus influenzae
Figure 2 Receiver operating characteristic (ROC) curves of the
other parameters studied (CSF, cerebrospinal fluid; Se, serum).
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Page 6 of 9(one), and Streptococcus pneumoniae (one). The sensi-
tivity of this parameter for the differential diagnosis of
BM was 69%, and the specificity was 100% at a diag-
nostic cut-off level of 0.5 ng/ml. In another study on
12 patients with BM, reported by Hoffmann et al. [40],
PCT was undetectable in the serum of three patients;
in this study, the patients had postoperative meningitis
rather than community-acquired BM. According to
Jereb et al.[ 4 1 ] ,o nt h eb a s i so f2 0p a t i e n t sw i t hB M ,a
diagnostic cut-off level of 0.5 ng/ml had a sensitivity of
90% and a specificity of 100% for the differential diag-
nosis of BM. In this study, PCT levels < 0.5 ng/ml
were found in two patients with BM caused by Listeria
monocytogenes. More recently, Ray et al. [17] published
the results of a study in which PCT was assayed in
serum from eight patients with BM and a negative
direct CSF examination and 55 patients with VM. A
diagnostic cut-off level of 2.13 ng/ml had a sensitivity
of 87% and a specificity of 100% for the differential
d i a g n o s i so fB M .T h ed i a g n o s t i cc u t - o f fv a l u ed e f i n e d
in our study was 0.28 ng/ml, giving a sensitivity of 97%
and a specificity of 100%. However, this level was close
to the threshold of detection of PCT, 0.07 ng/ml.
Limitations of the study
The population selected for this study may be criticized.
All patients with meningitis and a direct examination of
CSF were included. We could have excluded patients
whose CSF appeared turbid macroscopically, but this
criterion may be subjective.
The causative virus was identified in only 39% of the
patients with VM. Improvements in PCR techniques
should make it possible to increase this rate in the
future. Among the patients classified as having VM in
our study, none received a prescription for an antibiotic
within 30 days after discharge from hospital, 11 experi-
enced persistent headaches for 5 days or more, before
these resolved spontaneously, and two were readmitted
to hospital (for post-lumbar puncture syndrome).
The number of patients included was too small, relative
to the number of parameters investigated, for us to con-
struct a model based on multivariate analysis to confirm
the diagnostic relevance of the parameters described.
The various published scores and models were not
tested in our study, as these were most often based on
heterogeneous populations, particularly with regard to
the age of the patients and the etiology of meningitis,
sometimes retrospectively [8,10,36,43,44].
Although PCT appeared to be one of the most highly
discriminative markers with regard to the differentiation
of BM and VM, we did not study the impact of serum
PCT level on the prescription or nonprescription of
antibiotics. Antibiotic treatment was prescribed in the
emergency unit to 31 patients in the VM group, even
though all these patients had a serum PCT level < 0.12
ng/ml. In the pediatric context, a study focusing on the
impact of serum PCT level on the duration of antibiotic
treatment was performed during an epidemic of menin-
gitis caused by enterovirus [45]. The treatment duration
was found to be shorter by 2.4 days per patient in the
group of patients with VM whose PCT level was deter-
mined 3 times per week.
Finally, we have not yet evaluated the impact of the
results of real-time PCR testing for enterovirus on the
prescription of antibiotics in patients with meningitis
and a negative direct CSF examination.
Conclusions
T h i ss t u d yc o n f i r m st h ev a l u eo fd e t e r m i n i n gs e r u m
PCT and CSF lactate concentrations for the differential
diagnosis of bacterial and viral meningitis, in the
absence of microbiologic pointers at the time of the
patient’s emergency admission to hospital.
It would be interesting to study the impact of evaluat-
ing these two parameters on the prescription of antibio-
tics in patients admitted to the emergency unit with
meningitis with clear CSF associated with a normal neu-
rologic examination andan e g a t i v ed i r e c tC S F
examination.
Key messages
￿ Identification of bacterial meningitis on direct
examination had low sensitivity
￿ Identification of bacterial meningitis with classic
biomarkers is insufficient
￿ Models for predicting the acute bacterial origin of
meningitis are not easy to use
￿ Cerebrospinal fluid lactate and procalcitonin are
easy to determine
￿ Cerebrospinal fluid lactate and procalcitonin are
the best markers for differentiating between bacterial
and viral meningitis
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